Skip to main content
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ATNM ISIN · US00507W2061 LEI · 549300LCY1NZSXCQDT45 US Manufacturing
Open in API
Filings indexed 493 across all filing types
Latest filing 2013-11-21 Regulatory Filings
Country US United States of America
Listing US ATNM

About Actinium Pharmaceuticals, Inc.

https://www.actiniumpharma.com/

Actinium Pharmaceuticals, Inc. is a clinical-stage company focused on developing targeted radiotherapies for patients with cancers lacking effective treatment options. The company's platform utilizes potent radioisotopes, such as the alpha-emitter Actinium-225, conjugated to monoclonal antibodies to precisely deliver radiation to cancer cells. Its clinical pipeline addresses hematologic malignancies and solid tumors. Key programs include Iomab-B, a targeted conditioning agent for bone marrow transplant in patients with relapsed or refractory Acute Myeloid Leukemia (AML), and Actimab-A, a CD33-targeting therapy for AML. The company is also advancing ATNM-400, a novel non-PSMA therapeutic for prostate cancer, and developing its proprietary Actinium-225 manufacturing technology and infrastructure.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2013
Regulatory Filings
2013-11-21 English
PROSPECTUS SUPPLEMENT
Interim / Quarterly Report Classification · 100% confidence The document is a Form 10-Q quarterly report filed with the SEC for the quarter ended September 30, 2013 by Actinium Pharmaceuticals, Inc. It includes detailed unaudited financial statements, management's discussion and analysis, and other required disclosures typical of a quarterly report. The presence of financial statements, MD&A, and the SEC form designation 10-Q clearly identifies this as an Interim / Quarterly Report. The document length (15,000 characters) and content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is IR (Interim / Quarterly Report).
2013-11-19 English
CURRENT REPORT
Call Transcript Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which includes a transcript of a webinar and a press release. The transcript is attached as Exhibit 99.1 and the press release as Exhibit 99.2. The document does not contain financial statements or detailed financial analysis but rather disclosures of corporate developments and a press release. The presence of a webinar transcript suggests this is a conference call or similar event. Given the content and format, this fits best as a Call Transcript (CT) filing type. The document length is 3270 characters, which is short and consistent with a transcript or announcement rather than a full report. Therefore, the classification is CT with high confidence.
2013-11-18 English
QUARTERLY REPORT
Interim / Quarterly Report Q3 2013
2013-11-14 English
PROSPECTUS
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus filed pursuant to Rule 424(b)(3) with the SEC, describing a public offering of common stock and warrants by selling stockholders. It includes extensive information about the securities offered, risk factors, business overview, use of proceeds, management discussion and analysis, and other disclosures typical of a prospectus. The document is not an annual or quarterly report, earnings release, or management discussion standalone. It is not a proxy statement, voting results, or a regulatory filing of a different nature. The presence of the term 'prospectus' and the detailed description of the offering, selling stockholders, and securities indicates this is a capital markets document related to financing. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual prospectus, not just an announcement or summary.
2013-11-13 English
OWNERSHIP DOCUMENT
Director's Dealing
2013-11-13 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.